Effects of Two Endurance Training Programs on 5-km Running Performance in Recreational Runners
30 de julho de 2026 atualizado por: Shuqi Jia
Effects of Lactate Threshold Training and Pyramidal-to-Polarized Endurance Training on 5-km Running Performance, Physiological Capacity, and Post-exercise Neural Responses in Recreational Runners: A Randomized Controlled Trial
This study will examine the effects of two 8-week endurance training programs on 5-km running performance in recreational runners. Participants will be randomly assigned to a lactate threshold training group, a pyramidal-to-polarized endurance training group, or a control group that maintains usual physical activity without receiving the study training program.
Before and after the intervention, participants will complete assessments of 5-km running performance, aerobic fitness, lactate threshold, running economy, blood lactate responses, and brain activity recorded before and after maximal exercise. The study will compare changes among the three groups and examine whether physiological and post-exercise neural responses are associated with improvements in running performance.
The main purpose is to determine whether the two training programs produce different improvements in 5-km running performance and to better understand the physiological and neural adaptations associated with endurance training in recreational runners.
Visão geral do estudo
Status
Ainda não está recrutando
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Estimado)
60
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Shuqi Jia
- Número de telefone: +8613327732991
- E-mail: jsq2221111006@163.com
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Sim
Descrição
Inclusion Criteria:
- Men and women aged [18-30] years.
- Recreational runners with regular running or endurance-training experience for at least [6 months].
- Currently completing running training at least [2-3 times per week].
- Able to complete a continuous 5-km run.
- Willing and able to complete the 8-week training intervention and all study assessments.
- Able to understand the study procedures and provide written informed consent.
Exclusion Criteria:
- Current cardiovascular, respiratory, metabolic, neurological, or other medical conditions that may contraindicate maximal exercise or endurance training.
- Current musculoskeletal injury or pain that limits running or participation in maximal exercise testing.
- History of loss of consciousness, epilepsy, severe head injury, or other neurological conditions that may affect electroencephalographic recordings.
- Use of medications or substances known to substantially affect cardiovascular, metabolic, or central nervous system responses to exercise.
- Participation in another structured exercise intervention or clinical study during the study period.
- Inability or unwillingness to comply with the assigned training program, testing procedures, or study requirements.
- Any other condition judged by the investigators to make participation unsafe or to substantially affect the validity of the study outcomes.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Lactate Threshold Training Group
Participants assigned to this group will complete an 8-week endurance training program primarily prescribed around their individually determined lactate threshold intensity.
Training intensity will be individualized using baseline physiological testing and adjusted according to the study protocol.
Participants will complete the prescribed training sessions throughout the intervention period and will undergo the same pre- and post-intervention assessments as the other study groups.
|
Participants will complete an 8-week individualized endurance training program prescribed primarily around the lactate threshold.
Training intensity will be determined from baseline physiological testing.
The program will specify the frequency, duration, and intensity of each training session and will be adjusted according to the study protocol.
|
|
Experimental: Pyramidal-to-Polarized Endurance Training Group
Participants assigned to this group will complete an 8-week periodized endurance training program in which the training-intensity distribution progresses from a pyramidal pattern during the initial phase to a polarized pattern during the later phase.
Exercise intensity will be individualized using baseline physiological testing and adjusted according to the study protocol.
Participants will undergo the same pre- and post-intervention assessments as the other study groups.
|
Participants will complete an 8-week individualized endurance training program in which the training-intensity distribution progresses from a pyramidal pattern during the initial phase to a polarized pattern during the later phase.
Training intensity will be prescribed using individually determined physiological thresholds obtained from baseline testing.
The program will include low-, moderate-, and high-intensity running sessions, with the relative distribution of training time across intensity zones adjusted according to the planned periodization.
Training frequency, session duration, and intensity will be standardized according to the study protocol and monitored throughout the intervention.
|
|
Sem intervenção: Usual Activity Control Group
Participants assigned to this group will continue their usual physical activity and running habits during the 8-week study period and will not receive either of the structured training programs administered by the research team.
Participants will be asked not to begin any new structured endurance training program during the intervention period and will undergo the same pre- and post-intervention assessments as the training groups.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in 5-km Running Performance
Prazo: Baseline and immediately after the 8-week intervention
|
5-km running performance will be assessed using a maximal-effort self-paced 5-km run conducted on a standard 400-m outdoor athletics track.
Completion time will be recorded in seconds.
The primary outcome will be the change in 5-km completion time from baseline to the end of the 8-week intervention.
A lower completion time indicates better running performance.
|
Baseline and immediately after the 8-week intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Maximal Oxygen Uptake
Prazo: Baseline and immediately after the 8-week intervention
|
Maximal oxygen uptake will be assessed during a graded cardiopulmonary exercise test performed to volitional exhaustion.
Oxygen uptake will be measured breath-by-breath and expressed relative to body mass in milliliters per kilogram per minute.
The outcome will be the change in maximal oxygen uptake from baseline to the end of the 8-week intervention.
|
Baseline and immediately after the 8-week intervention
|
|
Change in Lactate Threshold
Prazo: Baseline and immediately after the 8-week intervention
|
Lactate threshold will be determined during an incremental running test using blood lactate measurements and the prespecified threshold-identification method described in the study protocol.
The outcome will be the change in running speed or physiological intensity corresponding to the lactate threshold from baseline to the end of the 8-week intervention.
|
Baseline and immediately after the 8-week intervention
|
|
Change in Running Economy
Prazo: Baseline and immediately after the 8-week intervention
|
Running economy will be assessed during steady-state submaximal treadmill running at a standardized speed.
Oxygen uptake will be measured during the steady-state period and expressed relative to body mass.
The outcome will be the change in oxygen cost of running from baseline to the end of the 8-week intervention.
A lower oxygen cost at the same running speed indicates better running economy.
|
Baseline and immediately after the 8-week intervention
|
|
Change in Post-exercise Blood Lactate Concentration
Prazo: Baseline and immediately after the 8-week intervention, with measurements before exercise and at 5 and 20 minutes after exercise
|
Capillary blood lactate concentration will be measured at prespecified time points before and after maximal exercise.
The outcome will include changes in post-exercise blood lactate concentration and lactate recovery from baseline to the end of the 8-week intervention.
Blood lactate concentration will be expressed in millimoles per liter.
|
Baseline and immediately after the 8-week intervention, with measurements before exercise and at 5 and 20 minutes after exercise
|
|
Change in Post-exercise Electroencephalographic Activity
Prazo: Baseline and immediately after the 8-week intervention, with electroencephalographic recordings before exercise and at 5 and 20 minutes after exercise
|
Resting electroencephalographic activity will be recorded before maximal exercise and during recovery after exercise.
Prespecified electroencephalographic outcomes will include relative spectral power in selected frequency bands and cortical regions.
The outcome will be the change in post-exercise electroencephalographic responses from baseline to the end of the 8-week intervention.
|
Baseline and immediately after the 8-week intervention, with electroencephalographic recordings before exercise and at 5 and 20 minutes after exercise
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Event-Related Potential Responses During Cognitive Tasks
Prazo: Baseline and immediately after the 8-week intervention, with recordings before exercise and at 5 and 20 minutes after maximal exercise
|
Event-related potentials will be recorded during prespecified cognitive tasks before and after the 8-week intervention.
Prespecified outcomes will include the amplitude and latency of selected ERP components, including N2 and P3 components, at predefined scalp regions and task conditions.
The outcome will be the change in ERP amplitude and latency from baseline to the end of the intervention, as well as changes in the acute ERP response from before to after maximal exercise.
|
Baseline and immediately after the 8-week intervention, with recordings before exercise and at 5 and 20 minutes after maximal exercise
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Estimado)
1 de agosto de 2026
Conclusão Primária (Estimado)
1 de outubro de 2026
Conclusão do estudo (Estimado)
8 de novembro de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
28 de julho de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
28 de julho de 2026
Primeira postagem (Real)
31 de julho de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
3 de agosto de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
30 de julho de 2026
Última verificação
1 de julho de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- SUS-5KM-RCT-2026
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
Individual participant data will not be shared because the current informed consent and ethics-approved study documents do not include provisions for external sharing of participant-level data.
Aggregate results may be reported in publications.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .